4D Molecular Therapeutics Inc (FDMT)
10.83
-0.13
(-1.19%)
USD |
NASDAQ |
Sep 27, 16:00
10.84
0.00 (0.00%)
Pre-Market: 20:00
4D Molecular Therapeutics Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.047M |
| September 30, 2021 | 0.791M |
| June 30, 2021 | 1.218M |
| Date | Value |
|---|---|
| March 31, 2021 | 0.965M |
| December 31, 2020 | 1.486M |
| September 30, 2020 | 0.896M |
| December 31, 2019 | 0.978M |
| June 30, 2019 | 1.161M |
| December 31, 2018 | 1.124M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2022
1.486M
Maximum
Dec 2020
0.6381M
Average
0.8435M
Median
Accounts Receivable (Quarterly) Benchmarks
| Johnson & Johnson | 15.79B |
| Regeneron Pharmaceuticals Inc | 5.717B |
| Journey Medical Corp | 10.46M |
| NovaBay Pharmaceuticals Inc | 0.547M |
| Palatin Technologies Inc | 0.00 |